iShares U.S. Pharmaceuticals ETF ( IHE ) is a buy due to the strengths of its top holdings, which have diverse and successful product lines. Additionally, many of these top pharmaceutical holdings are seeing strong growth withWilson Research seeks to provide investors with focused insights on predominantly exchange-traded funds, or ETFs, with a blend between growth potential and dividend yield. The analysis provided emphasizes fundamental analysis while including macro-level factors such as industry trends, ...